Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)

Starting soon · Phase 4 · Has a placebo group

Conditions studied: Primary Open Angle Glaucoma

In brief

The primary objective of this study is to determine if the addition of Rocklatan post-Hydrus will provide additional intraocular pressure lowering.

Key facts

Study ID
NCT07048886
Run by
Center for Sight Las Vegas
People needed
68
Starts
2025-07-15
Expected to finish
2026-12-31
Last updated by the study team
2025-07-03

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.